14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
PASG vs AAME: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Atlantic American Corp (AAME) is the stronger overall head-to-head candidate over Passage Bio, Inc. (PASG) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). PASG carries a Unified Composite Score of 22.5/100 (STRONG SELL) at $4.13 (N/M Forward P/E, 0.0% operating margin), whereas AAME carries 42.1/100 (HOLD) at $1.18 (7.4x Forward P/E, 5.1% operating margin).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PASG vs AAME. Trailing 12-month operating profitability (PASG 0.0% vs AAME 5.1%) and valuation multiples (PASG N/M vs AAME 7.4x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Insurance - Life value chain with $25.7M market capitalization and 5.1% operating margin.
OpEx & R&D Reinvestment7.9% of Rev ($17M)
90D Engineering Disclosures0 Published
Investor FAQ PASG vs AAME Key Questions & Quantitative Answers
As of Nov 16, 2026, Atlantic American Corp (AAME) is the stronger overall head-to-head candidate over Passage Bio, Inc. (PASG) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). PASG carries a Unified Composite Score of 22.5/100 (STRONG SELL) at $4.13 (N/M Forward P/E, 0.0% operating margin), whereas AAME carries 42.1/100 (HOLD) at $1.18 (7.4x Forward P/E, 5.1% operating margin). Technically, PASG sits in a Neutral phase (RSI 57.0, UNCLASSIFIED options structure) and AAME sits in a Neutral phase (RSI 47.8, UNCLASSIFIED options structure).
AAME leads the Growth & Scale pillar: PASG posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with AAME at +4.8% YoY revenue growth and -59.7% YoY earnings growth on $210M TTM revenue (13.0% gross margin, 5.1% operating margin). On trailing 12-month operating scale, PASG generates N/A in USD-normalized revenue versus $210M for AAME. In operating R&D and SG&A reinvestment, PASG deploys N/A (0 90-day corporate R&D disclosures) versus 7.9% of Rev ($17M) (0 disclosures) for AAME.
AAME screens cheaper on headline valuation multiples. PASG trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin), whereas AAME trades at 7.4x Forward P/E, 4.5x Trailing P/E, 2.43x PEG, and 0.1x EV/Revenue (11.5% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PASG (-212.3% ROE) versus AAME (5.2% ROE) capital efficiency.
In options market volatility and institutional positioning, PASG carries 0.0% implied volatility (50th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.72β · 94% Vol realized risk). By comparison, AAME carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.92β · 116% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.